Detalhe da pesquisa
1.
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses.
Cell
; 185(5): 872-880.e3, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123650
2.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
; 184(21): 5432-5447.e16, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619077
3.
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
Cell
; 182(5): 1295-1310.e20, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841599
4.
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Cell
; 183(5): 1367-1382.e17, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160446
5.
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Nature
; 594(7862): 253-258, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33873199
6.
PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro.
Malar J
; 17(1): 135, 2018 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609625
7.
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.
Cell Rep
; 40(9): 111299, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988541
8.
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.
Sci Transl Med
; 14(646): eabn1252, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412328
9.
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses.
bioRxiv
; 2021 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931192
10.
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
Science
; 373(6555): 648-654, 2021 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210893
11.
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.
Front Immunol
; 12: 710263, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267764
12.
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429.
bioRxiv
; 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821281
13.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
bioRxiv
; 2021 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758839
14.
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.
bioRxiv
; 2021 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594366
15.
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding.
bioRxiv
; 2020 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32587970
16.
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.
bioRxiv
; 2020 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817941
17.
Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.
JCI Insight
; 3(1)2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321371
18.
An Opsonic Phagocytosis Assay for Plasmodium falciparum Sporozoites.
Clin Vaccine Immunol
; 24(2)2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881488